Work with us

YBRI has developed a long term integrated strategy for biomedical science in York, providing an optimal structure for the delivery of biomedical research excellence.

We are here to facilitate and nurture interdisciplinary research in biomedical research both in York and beyond through working with organisations and independent research fellows.

External organisations

Who can work with us?

Pharmaceutical companies
Biotech companies
Businesses
Government bodies
UK and international universities
Research institutes
Charities
Non-governmental organisations
National Health Service (NHS)
Private healthcare providers

How can we help?

Provide consultancy, advice, knowledge and expertise from world-leading academic
Facilitate contact with relevant biomedical researchers at York and within our wider network
Conduct collaborative research on your behalf and in partnership
Host events and workshops to create networking opportunities
Publicise the outputs and impacts of projects

YBRI members have colleagues, collaborators and partners locally, nationally and internationally in academic institutions, hospitals and industry. If you’d like to know more, please get in touch.

Examples of our engagement with industry

Professor Jeremy Mottram works with the Novartis Institute of Tropical Diseases to identify novel chemical entities that may be developed into treatment for leishmaniasis (Khare, Nature 2016) and human African trypanosomiasis (Saldivia, Nature Microbiology 2020).
- Contact: jeremy.mottram@york.ac.uk
Professor Jennifer Southgate and her team in the Jack Birch Unit for Molecular Carcinogenesis have a functionally-differentiated human urothelial tissue platform (bladder and ureter) available through Kystis for collaborative and contract research partnerships. Potential applications include urinary tract infections and drug toxicity.
- Contact: info@kystis.com
Professor Ian Hitchcock is working with Incyte to elucidate novel mechanisms in myeloproliferative neoplasm development in order to develop more targeted therapies.
- Contact: ian.hitchcock@york.ac.uk
Professor Steve Johnson and Professor Thomas Krauss work with Aptamer Group to identify and characterise novel Optimer binding agents that can easily be integrated into low-cost and handheld diagnostic devices (Kenaan, Biosense. Bioelect. 2020)
Professor Neil Hunt collaborates with UCB on the development of novel high throughput screening methods based on 2D-IR spectroscopy for use in drug design applications.
- Contact: neil.hunt@york.ac.uk

**Dr Katherine Bridge**, Kay Kendall Leukaemia Fund Intermediate Research Fellow, Biology

Our research

Our research spans three main research themes:

and two cross-cutting themes: